Healthcare major Manipal Hospitals reported a 21.6 per cent year-on-year (y-o-y) increase in profit after tax (PAT), excluding exceptional items, to ₹380.2 crore for the second quarter of FY27.
However, PAT including exceptional items declined 10.3 per cent to ₹285 crore, compared with ₹317.8 crore in Q2 FY26.
Revenue from operations rose 37.3 per cent y-o-y to ₹3,399.4 crore during the quarter. Inpatient volumes grew 35 per cent to around 169,000, while outpatient volumes increased 27.2 per cent to approximately 1.74 million.
Occupancy improved by 160 basis points y-o-y to 70.1 per cent, with average operational capacity at 7,331 beds and average length of stay at 2.8 days.
The company said that, excluding the post-tax interest of ₹75 crore on non-convertible debentures (NCDs) raised for the Sahyadri acquisition in Q2 FY27, PAT stood at approximately ₹455 crore.
For H1 FY27, after excluding ₹165 crore in such interest, PAT was approximately ₹804 crore. These figures represented y-o-y growth of 45.6 per cent and 37.4 per cent, respectively.
The company’s average revenue per operating bed (ARPOB) remained at ₹70,600 per day on a consolidated basis.
However, excluding Sahyadri, ARPOB for Q2 and H1 FY27 stood at ₹76,600 and ₹76,900 per day, respectively, representing y-o-y growth of 8.5 per cent and 8.6 per cent.
The 300-licensed-bed Electronic City hospital in Bengaluru commenced operations during the quarter, taking Manipal Hospitals’ total licensed bed capacity to 13,440 as of September 30, 2026.
During H1 FY27, oncology revenue grew 51 per cent y-o-y, followed by neurosciences at 47 per cent and orthopaedics at 44 per cent. Cardiac sciences, gastroenterology and renal sciences recorded growth of 39 per cent, 36 per cent and 38 per cent, respectively.
Commenting on the performance, Dilip Jose, Managing Director and CEO of Manipal Hospitals, said: “We are pleased that our performance this quarter has been driven by volumes, with more patients accessing our care, and we believe this is the sustainable option for growth in care delivery. Improved capacity utilisation, particularly in high-acuity specialties, continued to be a key driver while maintaining focus on strengthening our clinical capabilities, improving operational performance and building a more integrated healthcare platform.”
Published on November 13, 2026
